Antigenicity and Immunogenicity of Plasmodium vivax Merozoite Surface Protein-3

A recent clinical trial in African children demonstrated the potential utility of merozoite surface protein (MSP)-3 as a vaccine against Plasmodium falciparum malaria. The present study evaluated the use of Plasmodium vivax MSP-3 (PvMSP-3) as a target antigen in vaccine formulations against malaria...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Bitencourt, Amanda R., Vicentin, Elaine C., Jimenez, Maria C., Ricci, Ricardo, Leite, Juliana A., Costa, Fabio T., Ferreira, Luis C., Russell, Bruce, Nosten, François, Rénia, Laurent, Galinski, Mary R., Barnwell, John W., Rodrigues, Mauricio M., Soares, Irene S.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Public Library of Science 2013
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3573074/
https://ncbi.nlm.nih.gov/pubmed/23457498
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0056061
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge